Reply to Lee and Howden
Clin Infect Dis
.
2018 Jan 6;66(1):160-161.
doi: 10.1093/cid/cix751.
Authors
Abigail L Manson
1
,
Thomas Abeel
1
2
,
James Galagan
3
4
,
Jagadish Chandrabose Sundaramurthi
5
,
Siva Kumar Shanmugam
5
,
Kannan Palaniyandi
5
,
Sujatha Narayanan
5
,
Soumya Swaminathan
5
,
Ashlee M Earl
1
Affiliations
1
Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
2
Delft Bioinformatics Lab, Delft University of Technology, the Netherlands.
3
Department of Biomedical Engineering, Boston University, Massachusetts.
4
National Emerging Infectious Diseases Laboratory, Boston University, Massachusetts.
5
National Institute for Research in Tuberculosis, Chennai, India.
PMID:
29040415
PMCID:
PMC6248590
DOI:
10.1093/cid/cix751
No abstract available
Publication types
Letter
Comment
MeSH terms
Diagnostic Tests, Routine
Drug Resistance, Bacterial
India
Mycobacterium tuberculosis*
Grants and funding
U19 AI110818/AI/NIAID NIH HHS/United States